Volume 13 • Number 12 • December 2012

Two hot health issues collided last month: vaccines and women’s health. The report that pregnant women getting the Flu shot have twice the risk of bearing children with Autism[1] should have given everyone pause; it did not. This is not to say that we should stop vaccinating, bu
Read More

Volume 13 • Number 11 • November 2012

The elections are upon us; I hope you get out and vote. However, I have little hope that the candidates on either side of the aisle will fix the mess we are in. In general, I feel they are all in the pocket of corporations and super-bankers. In particular, the health care system will
Read More

Volume 13 • Number 10 • October 2012

The institute of Medicine reported that each year we waste $765 Billion on Health Care,[1] a figure disturbingly similar to the Corporate Bailout of 2008. These are heady figures, especially while we are debating whether to implement Health Care reforms. It seems to me that as a socie
Read More

Volume 13 • Number 9 • September 2012

We have discussed “obesogens,” or chemicals that compromise our metabolism in depth in past issues. They do so mainly by interfering with cell membrane function, which leads to insulin resistance, and by compromising how we detoxify said chemicals in the liver. The more co
Read More

Volume 13 • Number 8 • August 2012

The last few issues have concentrated on “systems biology,”[1] the science behind our network of interconnected cells working together in a perfect symphony of cell communication: “In the 21st century, researchers have moved beyond the concept that diseases exist ind
Read More

Volume 13 • Number 7 • July 2012

This special issue may be too technical for some; but, if you have been reading this newsletter on a regular basis you will do fine. It covers a most stunning issue of the Journal Science, a publication of the American Association for the Advancement of Science. This journal is widely
Read More

Volume 13 • Number 6 • June 2012

A recent study showed that osteoarthritis may boost the risk of heart disease.[1] Interestingly, other recent articles, seemingly unrelated and likely ignored, provide a clue: Colchicine, not allopurinol, cuts the risk of heart attacks in half,[2] and Ayurdevic treatment of gut proble
Read More

Volume 13 • Number 5 • May 2012

Recently, the FDA placed 16 pharmaceutical drugs on a “watch list” because of troubling side effects, which are better documented after drugs have been on the market much longer than the limited trials prior to their approval. This may serve as a reminder that one ofIntegr
Read More